Resonant Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,554
Closed -$212K – 524
2025
Q4
$212K Sell
1,554
-16
-1% -$2.3K 0.01% 417
2025
Q3
$232K Buy
+1,570
New +$218K 0.01% 388
2025
Q2
– Sell
-2,387
Closed -$285K – 425
2025
Q1
$285K Buy
2,387
+110
+5% +$13.6K 0.02% 299
2024
Q4
$264K Sell
2,277
-32
-1% -$4.05K 0.02% 292
2024
Q3
$312K Buy
2,309
+134
+6% +$17.9K 0.02% 275
2024
Q2
$295K Buy
2,175
+616
+40% +$83.8K 0.02% 271
2024
Q1
$201K Buy
+1,559
New +$188K 0.02% 331

Other funds holding XYL

Resonant Capital Advisors's XYL Position: Q1 2026 in Review

Resonant Capital Advisors sold out of Xylem (XYL) in Q1 2026, closing a stake of 1,554 shares — an estimated $212K sold.

Resonant Capital Advisors first reported a position in XYL in Q1 2024 and held it in 7 quarters. The position peaked at $312K in Q3 2024. 1,114 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Resonant Capital Advisors reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Resonant Capital Advisors sold 1,554 Xylem shares in Q1 2026, an estimated $212K.
  • Resonant Capital Advisors first reported a position in Xylem in Q1 2024 and held it in 7 quarters.
  • Resonant Capital Advisors's Xylem position peaked at $312K in Q3 2024.
  • 1,114 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Resonant Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.